Evaluation of the effects of the Sodium-glucose cotransporter 2 inhibitors and sacubitril/valsartan combined therapy in patients with HFrEF: echocardiographic study.
Tricuspid regurgitation: a narrative review focused on the missing points in the management of the less noble valve disease, directed to clinical practice
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
